Business
IperionX – June 2025 Quarterly Report
CHARLOTTE, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending June 30, 2025. Key highlights during and subsequent to the end of the quarter include: Commercial operations: production online and commissioning of all major equipment complete Successful commissioning of the Titanium Manufacturing Campus in Virginia, with all major scrap-to-forged titanium manufacturing equipment now online and
About this update from Iperionx Ltd.
CHARLOTTE, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending June 30, 2025. Key highlights during and subsequent to the end of the quarter include: Commercial operations: production online and commissioning of all major equipment complete Strong momentum across commercial and strategic customer partnerships U.S. Government backing to secure a low-cost domestic titanium supply chain Titanium production expansion plans fast-tracked Titan Critical Minerals Project: DFS to advance a vital U.S. critical minerals supply chain Strong financial position About IperionX IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions. Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States. IperionX’s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, hydrogen, automotive and additive manufacturing. A link to the full release can be found here . Contacts Anastasios (Taso) Arima, Founder and CEO Toby Symonds, President Dominic Allen, Chief Commercial Officer Investors: [email protected] Media: [email protected] +1 980 237 8900 www.iperionx.com